#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrodystrophy Osteopetrosis Infective uveitis Anaemia Hairy cell leukaemia Thermal burn Malignant neoplasm of choroid Ocular lymphoma Mantle cell lymphoma Muscular dystrophy Chronic lymphocytic leukaemia recurrent SAPHO syndrome Anal fistula Cerebellar ataxia Ehlers-Danlos syndrome More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Diagnostics Cystic fibrosis – Diagnostics Pleomorphic leiomyosarcoma – Diagnostics Adrenocortical carcinoma – Treatment Phenylketonuria – Diagnostics KBG syndrome – Trials in Disease Aicardi-Goutieres syndrome – Life with Disease Hereditary motor and sensory neuropathy Phenylketonuria – Treatment Idiopathic pulmonary fibrosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    INDAPAMIDE HEMIHYDRATE IDROXIOLEIC ACID Mps-106 Dexamethasone Acetate Phenol Tolu Balsam Noradrenaline Tartrate For-6219 Immunoglobulin M Corylus Avellana L. 20-HYDROXYECDYSONE Elranatamab Afatinib AZD3632 Thiocolchicoside ANTIMETABOLITES Maraviroc Rhh646 Aon-D21 Dexketoprofen More therapies…

    Learn about Your Condition

    Anal cancer recurrent Colon cancer metastatic Rectal cancer recurrent Coagulopathy Ankylosing spondylitis Alveolar bone defect Pancreaticoduodenectomy Behcet's syndrome Endocarditis enterococcal Hypersomnia Mantle cell lymphoma stage IV Exposure via breast milk Renal injury Myasthenia gravis Non-small cell lung cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Midostaurin and Chemotherapy for Children with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin
    • Fludarabine
    • Midostaurin
    Austria Czechia Germany Italy Poland Slovenia

  • Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

    Not recruiting

    2 1
    Investigated Diseases:
    • Acute kidney injury
    • Sepsis
    Investigated Drugs:
    • Tin816
    Austria Belgium Czechia France Germany Hungary +2

  • Study on the Effectiveness and Safety of REL-1017 for Patients with Major Depression Who Have Not Responded to Current Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Dextromethadone Hydrochloride
    Italy

  • Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lebrikizumab
    Austria Denmark France Italy Spain Sweden

  • Study on the Effects of Pasireotide in Patients with Low Blood Sugar After Bariatric Surgery

    Not recruiting

    2 1
    Investigated Diseases:
    • Hyperinsulinaemic hypoglycaemia
    • Postprandial hypoglycaemia
    Investigated Drugs:
    • Pasireotide Diaspartate
    • Placebo
    Belgium France Italy Spain

  • Study on Anifrolumab for Adults with Active Lupus Nephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Anifrolumab
    Belgium Bulgaria France Germany Hungary Italy +2

  • Study of Long-term Safety and Efficacy of Fitusiran in Patients with Hemophilia A or B with or without Inhibitory Antibodies to Factor VIII or IX

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophilia
    Investigated Drugs:
    • Antithrombin Iii Human
    • Factor Viii Inhibitor Bypassing Fraction
    • Fitusiran
    Denmark France Hungary Ireland Italy

  • Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

    Not recruiting

    2 1
    Investigated Drugs:
    • Nnc0194-0499
    • Cagrilintide
    • Semaglutide
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Study on the Effects of VS-01 for Adults with Acute-on-Chronic Liver Failure and Ascites

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute on chronic liver failure
    Investigated Drugs:
    • Citric Acid, Anhydrous Ph. Eur.
    Belgium France Germany Hungary Italy Spain

  • Study on the Effects of GSK3915393 for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Gsk3915393
    France Germany Italy The Netherlands Poland Spain
Previous Page
1 … 32 33 34 35 36 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!